Oncorus to Present at the Jefferies London Healthcare Conference
November 17 2021 - 7:00AM
Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company
focused on driving innovation to transform outcomes for cancer
patients, today announced that President and Chief Executive
Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will present at the
Jefferies London Healthcare Conference.
The presentation will be available for on-demand
viewing beginning Thursday, November 18, 2021 at 3:00 a.m. ET under
the Investors & Media section of Oncorus’ website
at https://investors.oncorus.com/. A replay of the
presentation will be archived on Oncorus’ site for 30 days
following the event.
About OncorusAt Oncorus, we are
focused on driving innovation to deliver next-generation viral
immunotherapies to transform outcomes for cancer patients. We are
advancing a portfolio of intratumorally (iTu) and intravenously
(IV) administered viral immunotherapies for multiple indications
with significant unmet need based on our oncolytic Herpes Simplex
Virus (HSV) Platform and Synthetic viral RNA (vRNA) Immunotherapy
Platform.
Designed to deliver next-generation viral
immunotherapy impact, our HSV Platform improves upon key
characteristics of this therapeutic class to enhance systemic
activity. Our lead HSV program, ONCR-177, is designed to be
directly administered into a tumor, resulting in high local
concentrations of the therapeutic agent and its five encoded
transgenes, as well as low systemic exposure to the therapy, which
could limit systemic toxicities. Our pioneering Synthetic vRNA
Immunotherapy Platform involves a highly innovative, novel
combination of RNA- and oncolytic virus-based modalities designed
to realize the potential of RNA medicines for cancer. Our lead
IV-administered Synthetic vRNA Immunotherapy clinical candidates,
ONCR-021 and ONCR-788, are both currently in IND-enabling
studies.Please visit www.oncorus.com to learn more.
Media
Contact: Liz
Meloneliz@scientpr.com Investor
Contact:Stern Investor Relations Julie
SeidelJulie.seidel@sternir.com
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Aug 2023 to Aug 2024